If the government's moving down this route, would you be able to advise the government? Maybe somebody should take a look at these data and see how they will affect the market. Brian mentioned the example of Germany where perhaps certain drugs would not be available if Canada's market is closed and we don't have a little bit of competition maintained in the market. At the end of the day, we're all thinking about the patients, and I am worried about market distortion here. Do you think that it would be a good idea for you to propose that to the minister?